Sensor Augmented Pump Therapy
Sponsors
Rabin Medical Center, University of Virginia, Daniel Chernavvsky, MD, CRC, University of Colorado, Denver, University of Cambridge
Conditions
ArrythmiaCystic Fibrosis Pulmonary ExacerbationCystic Fibrosis in ChildrenCystic Fibrosis-related DiabetesDiabetes MellitusDiabetes Mellitus, Type 1HypoglycemiaType 1 Diabetes
Unknown Phase
Overnight Type 1 Diabetes Control Under MD-Logic Closed Loop System at the Patient's Home
CompletedNCT01726829
Start: 2012-11-30End: 2015-12-31Updated: 2016-04-08
USS Virginia Closed-Loop for Overnight Control in Type 1 Diabetes
CompletedNCT02131766
Start: 2014-06-30End: 2015-03-31Updated: 2020-04-16
Full Day and Night Closed-Loop With DiAs Platform
CompletedNCT02147860
Start: 2014-05-31End: 2015-01-31Updated: 2016-07-19
Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp
CompletedNCT02604524
Start: 2016-01-31End: 2016-04-30Updated: 2018-09-19
Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes
WithdrawnNCT02733211
Start: 2019-03-31End: 2019-12-31Updated: 2019-12-30
Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management
TerminatedNCT03939065
Start: 2020-06-12End: 2022-06-30Updated: 2023-03-22
24/7 Closed-loop in Older Subjects With Type 1 Diabetes
CompletedNCT04025762
Start: 2019-09-01End: 2021-08-20Updated: 2024-12-06